Heart failure management: Caregiver versus care plan

Circulation

Volumn 108, Issue 2, 2003, Pages 129-131

  Kim, Daniel H ^b   Hunt, Sharon A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Aging; Editorials; Heart failure; Patients; Population

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CAREGIVER; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART FAILURE; HUMAN; MEDICAL SPECIALIST; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT SELECTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENCHMARKING; CANADA; CAREGIVERS; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; PATIENT CARE PLANNING; PHYSICIAN'S PRACTICE PATTERNS; RISK; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES;

EID: 0038108630     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000079617.56688.04     Document Type: Editorial

References (29)

1. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, Tex: American Heart Association; 2002.
2. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.
3. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068-3072.
4. O'Connell JB. The economic burden of heart failure. Clin Cardiol. 2000:23:III-6-III-10.
5. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102:1126-1131.
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
7. CIBIS II Investigators and Committees. The cardiac insufficiency study II (CIBIS II): a randomized trial. Lancet. 1999;353:9-13.
8. Oxman AD, Thomson MA, Davis DA, et al. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ. 1995;153:1423-1431.
9. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157:2460-2464.
10. Ansari M, Alexander M, Tutar A, et al. Cardiology participation improves outcomes in outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol. 2003;41:62-68.
11. Philbin EF, Weil HF, Erb TA, et al. Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes. Chest. 1999;116:346-354.
12. Edep ME, Shah NB, Tateo IM, et al. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30:518-526.
13. Jong P, Gong Y, Liu PP, et al. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. 2003;108:184-191.
14. Chin MH, Friedmann PD, Cassel CK, et al. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997;12:523-530.
15. Pugno PA, McPherson DS, Schmittling GT, et al. Results of the 2001 National Resident Matching Program: family practice. Fam Med. 2001;33:594-601.
16. Auerbach AD, Hamel MB, Davis RB, et al. Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 2000;132:191-200.
17. Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch Intern Med. 1999;159:1690-1700.
18. Philbin EF, DiSalvo TG. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol. 1999;33:1560-1566.
19. Morrow DA, Antman EM, Parsons L. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001;286:1356-1359.
20. Vrtovec B, Reynolds D, Zewail A, et al. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation. 2003;107:1764-1769.
21. Eichhorn EJ. Prognosis determination in heart failure. Am J Med. 2001;110:14S-36S.
22. Chin MH, Goldman L. Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol. 1997;79:1640-1644.
23. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation. 2001;104:2996-3007.
24. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39:83-89.
25. Weingarten S, Riedinger M, Conner L, et al. Reducing lengths of stay in the coronary care unit with a practice guideline for patients with congestive heart failure: insights from a controlled clinical trial. Med Care. 1994;32:1232-1243.
26. Armstrong PW. Do guidelines influence practice? Heart. 2003:89:349-352.
27. Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation. 2002;105:2861-2866.
28. McAlister FA, Lawson FME, Teo KK, et al. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 2001;110:378-384.
29. Blue L, Lang E, McMurray JJ, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ. 2001;323:715-718.